Task: Answer the multiple-choice question.
Question: Which drug exhibits a 6.013% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) Cc1cc(NC(=O)CSc2ncc(CO)n2Cc2ccc(F)cc2)no1
b) COc1cc(-c2noc(C)c2C#Cc2ccsc2)cc(OC)c1OC
Answer: a. Cc1cc(NC(=O)CSc2ncc(CO)n2Cc2ccc(F)cc2)no1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(NC(=O)CSc2ncc(CO)n2Cc2ccc(F)cc2)no1
Cc1cc(NC(=O)CSc2ncc(CO)n2Cc2ccc(F)cc2)no1
2-[1-[(4-fluorophenyl)methyl]-5-(hydroxymethyl)imidazol-2-yl]sulfanyl-N-(5-methyl-1,2-oxazol-3-yl)acetamide